Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11


Detection of AR-V7 in Liquid Biopsies of Castrate Resistant Prostate Cancer Patients: A Comparison of AR-V7 Analysis in Circulating Tumor Cells, Circulating Tumor RNA and Exosomes.

Nimir M, Ma Y, Jeffreys SA, Opperman T, Young F, Khan T, Ding P, Chua W, Balakrishnar B, Cooper A, De Souza P, Becker TM.

Cells. 2019 Jul 8;8(7). pii: E688. doi: 10.3390/cells8070688.


Tamoxifen-induced severe hot flashes and endoxifen levels: is dose reduction a safe and effective strategy?

Lee CI, Fox P, Balakrishnar B, Balleine RL, Gao B, Provan P, Coulter S, Liddle C, Hui R, Wong M, Gurney H, Wilcken N.

Breast. 2019 Aug;46:52-57. doi: 10.1016/j.breast.2019.05.009. Epub 2019 May 6.


Patterns of Presentation and Treatment Outcomes of Non-clear-cell Renal Cell Carcinoma and Sarcomatoid Renal Cell Carcinoma Patients in 2 Tertiary Referral Centers in Sydney, Australia.

Naher S, Padinharakam S, Balakrishnar B, Chua W, Descallar J, Adams D, de Souza P, Harrison M, Lim S.

Clin Genitourin Cancer. 2019 Jun;17(3):e565-e569. doi: 10.1016/j.clgc.2019.02.006. Epub 2019 Feb 27.


Patterns of immunotherapy use and management of toxicities in regional and tertiary settings.

Hamilton B, Xu K, Honeyball F, Balakrishnar B, Zielinski R.

Intern Med J. 2019 Aug;49(8):1010-1015. doi: 10.1111/imj.14235.


Dose individualization of sunitinib in metastatic renal cell cancer: toxicity-adjusted dose or therapeutic drug monitoring.

Sabanathan D, Zhang A, Fox P, Coulter S, Gebski V, Balakrishnar B, Chan M, Liddle C, Gurney H.

Cancer Chemother Pharmacol. 2017 Aug;80(2):385-393. doi: 10.1007/s00280-017-3362-1. Epub 2017 Jun 30.


CTC-mRNA (AR-V7) Analysis from Blood Samples-Impact of Blood Collection Tube and Storage Time.

Luk AWS, Ma Y, Ding PN, Young FP, Chua W, Balakrishnar B, Dransfield DT, Souza P, Becker TM.

Int J Mol Sci. 2017 May 12;18(5). pii: E1047. doi: 10.3390/ijms18051047.


Droplet Digital PCR Based Androgen Receptor Variant 7 (AR-V7) Detection from Prostate Cancer Patient Blood Biopsies.

Ma Y, Luk A, Young FP, Lynch D, Chua W, Balakrishnar B, de Souza P, Becker TM.

Int J Mol Sci. 2016 Aug 4;17(8). pii: E1264. doi: 10.3390/ijms17081264.


Patterns and trends in the incidence of paediatric and adult germ cell tumours in Australia, 1982-2011.

van Leeuwen MT, Gurney H, Turner JJ, Turner SL, Pearson SA, Laaksonen MA, Harnett P, Balakrishnar B, Sabanathan D, Vajdic CM.

Cancer Epidemiol. 2016 Aug;43:15-21. doi: 10.1016/j.canep.2016.05.006. Epub 2016 May 26.


Dose Escalation of Tamoxifen in Patients with Low Endoxifen Level: Evidence for Therapeutic Drug Monitoring-The TADE Study.

Fox P, Balleine RL, Lee C, Gao B, Balakrishnar B, Menzies AM, Yeap SH, Ali SS, Gebski V, Provan P, Coulter S, Liddle C, Hui R, Kefford R, Lynch J, Wong M, Wilcken N, Gurney H.

Clin Cancer Res. 2016 Jul 1;22(13):3164-71. doi: 10.1158/1078-0432.CCR-15-1470. Epub 2016 Feb 4.


Predictive value of CYP3A and ABCB1 phenotyping probes for the pharmacokinetics of sunitinib: the ClearSun study.

Kloth JS, Kl├╝mpen HJ, Yu H, Eechoute K, Samer CF, Kam BL, Huitema AD, Daali Y, Zwinderman AH, Balakrishnar B, Bennink RJ, Wong M, Schellens JH, Mathijssen RH, Gurney H.

Clin Pharmacokinet. 2014 Mar;53(3):261-269. doi: 10.1007/s40262-013-0111-4.


Evidence for therapeutic drug monitoring of targeted anticancer therapies.

Gao B, Yeap S, Clements A, Balakrishnar B, Wong M, Gurney H.

J Clin Oncol. 2012 Nov 10;30(32):4017-25. doi: 10.1200/JCO.2012.43.5362. Epub 2012 Aug 27. Review.


Supplemental Content

Loading ...
Support Center